S-Biomedic

OUR LIVE BACTERIA ARE THE FUTURE IN DERMATOLOGY AND COSMETIC INDUSTRY

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Barcelona, Spain
  • Currency EUR
  • Founded January 1111
  • Employees 2
  • Website sbiomedic.com

Company Summary

S-Biomedic has developed a method to change the human skin microbiome. We use our method to develop advanced cosmetics for acne recovery. Further development of applications includes skin aging, skin health and beauty, or validation into medical therapy of skin disorders such as eczema and rosacea.
Acne is one of the most common skin conditions affecting 85% of people at some point in their life. At the same time there is no satisfactory treatment in the market. Current acne products are either ineffective or they cause side effects ranging from skin irritation to birth defects.
Using advanced microbiome isolation we select natural skin bacteria and mix them into a multi-strain cosmetic formulation. The formulation of live bacteria displace pathogenic bacteria causing acne directly on the skin, naturally reestablish an equilibrated microbiome, and prevent relapse of acne.

Team

  • Veronika Oudova

  • Marc Güell
    CSO

    Marc is driving the technology of S-Biomedic. Currently Marc works as a postdoc in the lab of Dr. George Church at the Harvard Medical School. His research focuses on synthetic biology and biology technologies. He is an outstanding expert in microbiology, high-throughput sequencing and genomics. Marc is a scientific co-founder of the company eGenesis, a biotech company that focuses on commercialization of CRISPR based tools for genome editing.

  • Bernhard Paetzold
    CEO

    Bernhard is responsible for the product development. During his PhD studies at Centre for Genomic Regulation he worked together with Sanofi-Aventis on development of bacteria as a living pills. While working on this project he learned about the possibilities and problems that are connected to bacteria used as medication. Via the cooperation with Sanofi he also gained the insight in the requirements of such a product in the pharma industry

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free